Repligen Corp (RGEN)
141.76
+2.86
(+2.06%)
USD |
NASDAQ |
Nov 21, 16:00
141.70
-0.06
(-0.04%)
After-Hours: 20:00
Repligen Enterprise Value: 7.680B for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 7.680B |
| November 20, 2024 | 7.520B |
| November 19, 2024 | 6.937B |
| November 18, 2024 | 6.652B |
| November 15, 2024 | 6.726B |
| November 14, 2024 | 7.718B |
| November 13, 2024 | 8.168B |
| November 12, 2024 | 8.063B |
| November 11, 2024 | 7.554B |
| November 08, 2024 | 7.621B |
| November 07, 2024 | 7.799B |
| November 06, 2024 | 7.914B |
| November 05, 2024 | 7.915B |
| November 04, 2024 | 7.555B |
| November 01, 2024 | 7.504B |
| October 31, 2024 | 7.260B |
| October 30, 2024 | 7.379B |
| October 29, 2024 | 7.294B |
| October 28, 2024 | 7.425B |
| October 25, 2024 | 7.326B |
| October 24, 2024 | 7.311B |
| October 23, 2024 | 7.440B |
| October 22, 2024 | 7.813B |
| October 21, 2024 | 8.097B |
| October 18, 2024 | 7.971B |
| Date | Value |
|---|---|
| October 17, 2024 | 7.701B |
| October 16, 2024 | 7.479B |
| October 15, 2024 | 7.860B |
| October 14, 2024 | 7.752B |
| October 11, 2024 | 7.515B |
| October 10, 2024 | 7.273B |
| October 09, 2024 | 7.388B |
| October 08, 2024 | 7.302B |
| October 07, 2024 | 7.390B |
| October 04, 2024 | 7.397B |
| October 03, 2024 | 7.528B |
| October 02, 2024 | 7.762B |
| October 01, 2024 | 7.903B |
| September 30, 2024 | 8.076B |
| September 27, 2024 | 7.951B |
| September 26, 2024 | 8.021B |
| September 25, 2024 | 7.597B |
| September 24, 2024 | 7.779B |
| September 23, 2024 | 7.643B |
| September 20, 2024 | 7.785B |
| September 19, 2024 | 7.943B |
| September 18, 2024 | 7.733B |
| September 17, 2024 | 7.417B |
| September 16, 2024 | 7.619B |
| September 13, 2024 | 7.618B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
4.084B
Minimum
Nov 22 2019
17.34B
Maximum
Sep 23 2021
9.223B
Average
9.112B
Median
Dec 30 2022
Enterprise Value Benchmarks
| West Pharmaceutical Services Inc | 22.95B |
| QuidelOrtho Corp | 4.955B |
| Perspective Therapeutics Inc | -63.40M |
| Xtant Medical Holdings Inc | 85.83M |
| Catheter Precision Inc | 3.891M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.654M |
| Revenue (Quarterly) | 154.87M |
| Total Expenses (Quarterly) | 162.70M |
| EPS Diluted (Quarterly) | -0.01 |
| Gross Profit Margin (Quarterly) | 50.03% |
| Profit Margin (Quarterly) | -0.42% |
| Earnings Yield | -0.22% |
| Operating Earnings Yield | 0.15% |
| Normalized Earnings Yield | -0.4107 |